Dr. Alexander Sulakvelidze, Ph.D. is Chief Scientist of Intralytix, and an internationally recognized expert in phage technology. Dr. Sulakvelidze has published extensively on the subject of phage therapy, including co-editing a major book about bacteriophages in 2005. He is the author of several issued and pending patents in the field of phage therapy. Dr. Sulakvelidze is currently serving as Editor-in-Chief of the journal Bacteriophage, and as an ad hoc reviewer for several other journals and funding agencies.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)